A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Soft Tissue Open Surgeries
Phase of Trial: Phase III
Latest Information Update: 17 Apr 2019
Price : $35 *
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Registrational; Therapeutic Use
- Sponsors Grifols
- 26 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2015 Planned End Date changed from 1 Jun 2015 to 1 Jul 2015, according to ClinicalTrials.gov record.
- 07 May 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Jul 2015, according to ClinicalTrials.gov record.